Company Filing History:
Years Active: 2024-2025
Title: Innovations by Inventor Hyun Ji from Siheung-si, KR
Introduction: Hyun Ji, an innovative inventor located in Siheung-si, South Korea, has made significant contributions in the field of pharmaceutical chemistry. With a total of two patents under his name, his work focuses on improving the stability and effectiveness of efinaconazole, a compound used in medical treatments.
Latest Patents: Hyun Ji's latest patents demonstrate his expertise in developing advanced methods for preparing pharmaceutical compounds. His first patent, titled "Amorphous efinaconazole solid dispersion," proposes a solid dispersion that includes an amorphous form of efinaconazole combined with various stabilization carriers. This innovative approach minimizes thermodynamic deformation under ambient conditions, enhancing the stability and bioavailability of the compound.
The second patent, "Method for preparing efinaconazole using ionic liquid as medium," introduces a novel method for synthesizing efinaconazole. This method employs 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole in a coupling reaction with 4-methylenepiperidine or its organic salt, utilizing ionic liquid as the medium. This technique not only improves reaction efficiency but also allows for the production of efinaconazole with high purity and yield while preventing the formation of undesired byproducts.
Career Highlights: Hyun Ji is currently associated with Daebong LS Co., Ltd., where he actively contributes to the company's research and development efforts. His innovative approaches and expert knowledge in chemistry have established him as a valuable asset to the organization.
Collaborations: Throughout his career, Hyun Ji has collaborated with talented colleagues such as Eun Ju Park and Ji Eun Lee. Their collective expertise enhances their joint research efforts, leading to noteworthy advancements in the field of pharmaceutical sciences.
Conclusion: Hyun Ji's innovative contributions to the development of efinaconazole have the potential to make a significant impact in medical treatments. His patents reflect a commitment to improving pharmaceutical stability and efficacy, and his collaborations with skilled professionals further amplify the potential for future innovations.